FR2687047A1 - Anti-oviposition compositions comprising a fatty acid, a fatty acid alkyl ester and a monoterpene - Google Patents

Anti-oviposition compositions comprising a fatty acid, a fatty acid alkyl ester and a monoterpene Download PDF

Info

Publication number
FR2687047A1
FR2687047A1 FR9201506A FR9201506A FR2687047A1 FR 2687047 A1 FR2687047 A1 FR 2687047A1 FR 9201506 A FR9201506 A FR 9201506A FR 9201506 A FR9201506 A FR 9201506A FR 2687047 A1 FR2687047 A1 FR 2687047A1
Authority
FR
France
Prior art keywords
methyl
component
parts
thujone
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9201506A
Other languages
French (fr)
Other versions
FR2687047B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9201506A priority Critical patent/FR2687047B1/en
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Recherche Agronomique INRA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to CA002111708A priority patent/CA2111708A1/en
Priority to DE69205428T priority patent/DE69205428T2/en
Priority to AT92915124T priority patent/ATE128809T1/en
Priority to PCT/FR1992/000619 priority patent/WO1993000812A1/en
Priority to ES92915124T priority patent/ES2079198T3/en
Priority to EP92915124A priority patent/EP0592577B1/en
Publication of FR2687047A1 publication Critical patent/FR2687047A1/en
Application granted granted Critical
Publication of FR2687047B1 publication Critical patent/FR2687047B1/en
Priority to GR960400040T priority patent/GR3018620T3/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/12—Asteraceae or Compositae [Aster or Sunflower family], e.g. daisy, pyrethrum, artichoke, lettuce, sunflower, wormwood or tarragon
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof

Abstract

The invention relates to anti-oviposition compositions, which compositions comprise a component A which comprises at least one non-esterified C12-20 fatty acid and/or at least one C1-3 alkyl and C14-20 fatty acid ester, and a component B comprising at least one monoterpene present in an extract obtained by steam distillation of tansy flowers. The invention also relates to the application of the said compositions for the protection of plants against tortricid epidoptera.

Description

COMPOSITIONS ANTI-OVIPOSITION COMPRENANT UN ACIDE GRAS,
UN ALKYLESTER D'ACIDE GRAS, ET UN MONOTERPENE.ANTI-OVIPOSITION COMPOSITIONS COMPRISING FATTY ACID,
A FATTY ACID ALKYLESTER, AND A MONOTERPENE.

L'Invention est relative à des compositions anti-oviposition actives sur les lépidoptères tortricidés. The invention relates to anti-oviposition compositions active on tortricid lepidoptera.

Les lépidoptères tortricidés, également dénommés tordeuses, sont des insectes ravageurs causant d'importants dégâts aux cultures. Tortricid moths, also known as budworms, are insect pests that cause significant damage to crops.

Dans le cadre de leurs recherches ayant pour but la mise au point de nouvelles méthodes de lutte contre ces insectes, les Inventeurs ont précédemment identifié une phéromone anti-oviposition associée aux pontes de la tordeuse de la vigne (Lobesia botrana) (Demande de Brevet Français C.N.R.S.-I.N.R.A. no 91 08241) et ont obtenu des compositions anti-oviposition reproduisant l'effet de cette phéromone. Ces compositions sont actives, non seulement sur la tordeuse de la vigne, mais également sur d'autres espèces de tordeuses, en particulier la tordeuse orientale du pêcher, la carpocapse des pommes, et la cochylis. In the context of their research aimed at developing new methods of combating these insects, the Inventors have previously identified an anti-oviposition pheromone associated with the eggs of the grapevine budworm (Lobesia botrana) (French Patent Application CNRS-INRA no 91 08241) and obtained anti-oviposition compositions reproducing the effect of this pheromone. These compositions are active, not only on the vine budworm, but also on other species of budworms, in particular the eastern budworm of the peach tree, codling moth, and cochylis.

D'autre part, les Inventeurs ont également mis en évidence l'effet attractif sur les femelles de lépidoptères tortricidés, d'un extrait de tanaisie obtenu par distillation des fleurs à la vapeur d'eau et à partir des substances actives qu'ils ont identifiées, ont obtenu des compositions attractives, permettant par exemple le piègeage de ces insectes (Demande de Brevet Français
C.N.R.S.-I.N.R.A. no 91 08173). Or, les Inventeurs ont maintenant constaté que, de façon surprenante, l'addition de dérivés terpéniques présents dans l'extrait de tanaisie, à des compositions anti-oviposition telles que celles décrites dans la Demande 91 08241 augmentait considérablement l'activité de celles-ci.On the other hand, the inventors have also highlighted the attractive effect on females of tortricid lepidoptera, of a tansy extract obtained by distillation of the flowers with water vapor and from the active substances which they have identified, obtained attractive compositions, allowing for example the trapping of these insects (French Patent Application
CNRS-INRA no 91 08173). However, the inventors have now found that, surprisingly, the addition of terpene derivatives present in the tansy extract to anti-oviposition compositions such as those described in Application 91 08241 considerably increased the activity of these this.

La présente Invention a pour objet une composition anti-oviposition comprenant un composant A, lequel comprend au moins un acide gras non estérifié en C12-201 et/ou au moins un ester d'alkyle en C13 et d'acide gras en C14207 laquelle composition est caractérisée en ce que ledit composant A est associé à un composant B comprenant au moins un monoterpène présent dans un extrait obtenu par distillation de fleurs de tanaisie à la vapeur d'eau. The present invention relates to an anti-oviposition composition comprising a component A, which comprises at least one fatty acid not esterified in C12-201 and / or at least one alkyl ester in C13 and fatty acid in C14207 which composition is characterized in that said component A is associated with a component B comprising at least one monoterpene present in an extract obtained by distillation of tansy flowers with water vapor.

Selon un mode de réalisation préféré de la présente Invention, ledit monoterpène est choisi dans le groupe qui comprend lla-thujone, la 13-thujone et 1 'a-pinène.  According to a preferred embodiment of the present invention, said monoterpene is chosen from the group which comprises lla-thujone, 13-thujone and 1 a-pinene.

Selon une disposition préférée de ce mode de réalisation, le composant A comprend au moins un acide gras choisi dans le groupe qui comprend l'acide myristique, l'acide stéarique et l'acide palmitique, au moins un méthylester d'acide gras choisi dans le groupe qui comprend le palmitoléate de méthyle, le palmitate de méthyle, le linoléate de méthyle, le linolénate de méthyle, l'oléate de méthyle, le stéarate de méthyle, et le composant B comprend au moins un monoterpène choisi dans le groupe qui comprend lla-thujone, la 5-thujone et lla-pinène.  According to a preferred arrangement of this embodiment, component A comprises at least one fatty acid chosen from the group which comprises myristic acid, stearic acid and palmitic acid, at least one fatty acid methylester chosen from the group which comprises methyl palmitoleate, methyl palmitate, methyl linoleate, methyl linolenate, methyl oleate, methyl stearate, and component B comprises at least one monoterpene selected from the group which comprises lla-thujone, 5-thujone and lla-pinene.

Selon une modalité préférée de cette disposition, une composition conforme à l'Invention comprend, pour une partie de palmitoléate de méthyle, entre 4 et 10 parties de palmitate de méthyle, entre 2 et 5 parties de linoléate de méthyle, entre 2 et 5 parties de linolénate de méthyle, entre 4 et 10 parties d'oléate de méthyle, entre 2 et 5 parties de stéarate de méthyle, entre 2 et 5 parties d'acide myristique, entre 10 et 30 parties d'acide palmitique, entre 2 et 5 parties d'acide stéarique, entre 102 et 106 parties d'a-thujone, entre 10 et 104 parties de B-thujone et entre 102 et 106 parties dla-pinène.  According to a preferred form of this arrangement, a composition in accordance with the invention comprises, for a part of methyl palmitoleate, between 4 and 10 parts of methyl palmitate, between 2 and 5 parts of methyl linoleate, between 2 and 5 parts of methyl linolenate, between 4 and 10 parts of methyl oleate, between 2 and 5 parts of methyl stearate, between 2 and 5 parts of myristic acid, between 10 and 30 parts of palmitic acid, between 2 and 5 parts of stearic acid, between 102 and 106 parts of α-thujone, between 10 and 104 parts of B-thujone and between 102 and 106 parts of la-pinene.

Avantageusement, le composant A comprend au moins 10 ng/ml d'acide myristique, 10 ng/ml d'acide stéarique, 50 ng/ml d'acide palmitique, 5 ng/ml de palmito léate de méthyle, 20 ng/ml de palmitate de méthyle, 10 ng/ml de linoléate de méthyle, 10 ng/ml de linolénate de méthyle, 20 ng/ml d'oléate de méthyle, 10 ng/ml de stéarate de méthyle, et le composant B comprend au moins 10 mg/ml de B-thujone, 1 mg/ml dla-thujone et 10 mg/ml dla-pinène.  Advantageously, component A comprises at least 10 ng / ml of myristic acid, 10 ng / ml of stearic acid, 50 ng / ml of palmitic acid, 5 ng / ml of palmito methyl leate, 20 ng / ml of methyl palmitate, 10 ng / ml methyl linoleate, 10 ng / ml methyl linolenate, 20 ng / ml methyl oleate, 10 ng / ml methyl stearate, and component B comprises at least 10 mg / ml B-thujone, 1 mg / ml dla-thujone and 10 mg / ml dla-pinene.

De manière préférée, le composant A comprend entre 20 et 30 ng/ml d'acide myristique, entre 15 et 25 ng/ml d'acide stéarique, entre 100 et 150 ng/ml d'acide palmitique, entre 5 et 10 ng/ml de palmitoléate de méthyle, entre 30 et 80 ng/ml de palmitate de méthyle, entre 20 et 30 ng/ml de linoléate de méthyle, entre 15 et 25 ng/ml de linolénate de méthyle, entre 30 et 80 ng/ml d'oléate de méthyle, entre 25 et 35 ng/ml de stéarate de méthyle, et le composant B comprend entre 15 et 100 mg/ml de -thujone, entre 1 et 10 mg/ml d'a-thujone, entre 15 et 100 mg/ml d'a-pinène. Preferably, component A comprises between 20 and 30 ng / ml of myristic acid, between 15 and 25 ng / ml of stearic acid, between 100 and 150 ng / ml of palmitic acid, between 5 and 10 ng / ml methyl palmitoleate, between 30 and 80 ng / ml methyl palmitate, between 20 and 30 ng / ml methyl linoleate, between 15 and 25 ng / ml methyl linolenate, between 30 and 80 ng / ml d methyl oleate, between 25 and 35 ng / ml of methyl stearate, and component B comprises between 15 and 100 mg / ml of -thujone, between 1 and 10 mg / ml of a-thujone, between 15 and 100 mg / ml of a-pinene.

La présente Invention a également pour objet l'application des composants A et B, tels que définis plus haut, à la protection des plantes contre les
Lépidoptères tortricidés.The present invention also relates to the application of components A and B, as defined above, in the protection of plants against
Tortricid lepidoptera.

En particulier, la présente Invention a pour objet un procédé de protection des plantes contre les
Lépidoptères tortricidés, lequel procédé est caractérisé en ce que l'on met en contact les plantes à traiter avec le composant A et le composant B d'une composition antioviposition conforme à l'Invention.In particular, the subject of the present invention is a process for protecting plants against
Lepidoptera tortricidae, which process is characterized in that the plants to be treated are brought into contact with component A and component B of an antioviposition composition in accordance with the invention.

Selon un mode de réalisation préféré de ce procédé le composant A et le composant B sont appliqués simultanément. According to a preferred embodiment of this method, component A and component B are applied simultaneously.

Selon un autre mode de réalisation préféré de ce procédé, le composant A et le composant B sont appliqués successivement. According to another preferred embodiment of this method, component A and component B are applied successively.

La présente Invention sera mieux comprise à l'aide du complément de description qui va suivre, qui se réfère à des exemples de préparation et d'utilisation des compositions conformes à l'Invention. I1 va de soi toutefois que ces exemples sont donnés uniquement à titre d'illustration de l'objet de l'Invention dont ils ne constituent en aucune manière une limitation. The present invention will be better understood with the aid of the additional description which follows, which refers to examples of preparation and use of the compositions in accordance with the invention. It goes without saying, however, that these examples are given solely by way of illustration of the subject of the invention of which they do not in any way constitute a limitation.

EXEMPLE 1. - PREPARATION DUNE COMPOSITION ANTI-OVIPOSI
TION CONFORME A L'INVENTION
De l'acide myristique, de l'acide stéarique, de l'acide palmitique, du palmitoléate de méthyle, du palmitate de méthyle, du linoléate de méthyle, du linolénate de méthyle, de l'oléate de méthyle, du stéarate de méthyle, du B-thujone, de lla-thujone et du ss-pinène (SIGMA) sont mélangés dans les proportions indiquées dans le tableau I ci-dessous. Le mélange est dissous dans du méthanol.EXAMPLE 1 - PREPARATION OF AN ANTI-OVIPOSI COMPOSITION
TION CONFORMING TO THE INVENTION
Myristic acid, stearic acid, palmitic acid, methyl palmitoleate, methyl palmitate, methyl linoleate, methyl linolenate, methyl oleate, methyl stearate, B-thujone, lla-thujone and ss-pinene (SIGMA) are mixed in the proportions indicated in table I below. The mixture is dissolved in methanol.

TABLEAU I
ODP ODP+Thu+Pin ODP+Thu
Acide myristique 0,0052 0,0052 0,0052
Palmitate de méthyle 0,0117 0,0117 0,0117
Acide palmitique 0,0274 0,0274 0,0274
Linoléate de méthyle 0,0044 0,0044 0,0044
Linolénate de méthyle 0,0036 0,0036 0,0036
Oléate de méthyle 0,0122 0,0122 0,0122
Stéarate de méthyle 0,0058 0,0058 0,0058
Acide stéarique 0,0036 0,0036 0,0036
Palmitoléate de méthyle 0,0016 0,0016 0,0016
Beta thujone 0,9.105 0,9.105 0,9.105
Alpha thujone 8.103 8.103 8.103
Alpha pinène 1.105 1.105 1.105
Tableau 1 : Formulations proposées comme dissuasifs de ponte sur différentes espèces de tordeuses.TABLE I
ODP ODP + Thu + Pin ODP + Thu
Myristic acid 0.0052 0.0052 0.0052
Methyl palmitate 0.0117 0.0117 0.0117
Palmitic acid 0.0274 0.0274 0.0274
Methyl linoleate 0.0044 0.0044 0.0044
Methyl linolenate 0.0036 0.0036 0.0036
Methyl oleate 0.0122 0.0122 0.0122
Methyl stearate 0.0058 0.0058 0.0058
Stearic acid 0.0036 0.0036 0.0036
Methyl palmitoleate 0.0016 0.0016 0.0016
Beta thujone 0.9.105 0.9.105 0.9.105
Alpha thujone 8.103 8.103 8.103
Alpha pinene 1.105 1.105 1.105
Table 1: Formulations proposed as dissuasive spawning on different species of budworm.

Les quantités en acides ou esters sont exprimées en 10-9 g/dépôt. The amounts of acids or esters are expressed in 10-9 g / deposit.

EXEMPLE 2. - EFFICACITE DES COMPOSITIONS ANTI-OVIPOSITION
CONFORMES A L'INVENTION, SUR LA RéDUCTION DE LA PONTE DE L'EUDéMIS DE LA VIGNE
L'étude du comportement de ponte a été effectuée dans des cages en altuglass dans lesquelles a été déposé un substrat d'oviposition permettant la ponte, constitué par une feuille de papier bristol (10,7 x 13,6 cm).EXAMPLE 2 - EFFECTIVENESS OF ANTI-OVIPOSITION COMPOSITIONS
IN CONFORMITY WITH THE INVENTION, ON THE REDUCTION OF THE BRIDGE OF THE EUDEEMIS OF THE VINE
The study of the laying behavior was carried out in altuglass cages in which was deposited an oviposition substrate allowing the laying, constituted by a sheet of bristol paper (10.7 x 13.6 cm).

Sur chaque feuille de bristol ont été effectués 39 dépots, de 5 Rl chacun, de la solution à tester, (composition préparée comme décrit à l'exemple 1, ou solvant seul) à la concentration voulue ; les dépots sont espacés de 2,1 cm et ont un diamètre de 1,1 cm ; ils sont alternés avec des zones non traitées. On each Bristol board sheet, 39 deposits, of 5 Rl each, were made of the test solution (composition prepared as described in Example 1, or solvent alone) at the desired concentration; the deposits are spaced 2.1 cm apart and have a diameter of 1.1 cm; they are alternated with untreated areas.

Des supports témoins, non traités, ont également été utilisés
Les supports d'oviposition ont été placés dans les cages. 10 femelles âgées de 2 jours ont été laissées en présence des supports, pendant 1 nuit, à l'issue de laquelle le nombre et la disposition des oeufs déposés sur les zones traitées et sur les zones non traitées ont été notés
D'autre part, 24 heures après chaque expérience, les femelles sont placées dans des tubes de verre, afin de contrôler leur ponte ; les oeufs pondus par chaque femelle sont comptés.Untreated control media were also used
Oviposition supports were placed in the cages. 10 females aged 2 days were left in the presence of the supports, for 1 night, at the end of which the number and the arrangement of the eggs deposited on the treated areas and on the untreated areas were noted.
On the other hand, 24 hours after each experiment, the females are placed in glass tubes, in order to control their laying; the eggs laid by each female are counted.

A l'issue de l'expérimentation, on détermine l'indice anti-oviposition (Di), calculé en tenant compte du rapport entre l'aire non traitée, dont la superficie est le triple de celle de l'aire traitée, et l'aire traitée. At the end of the experiment, the anti-oviposition index (Di) is determined, calculated by taking into account the ratio between the untreated area, the area of which is three times that of the area treated, and l 'treated area.

Di = (A - 3B)/(A + 3B) x 100
A représentant le nombre moyen d'oeufs déposés (10 expériences) sur les parties non traitées, et B sur les parties traitées. Di = (A - 3B) / (A + 3B) x 100
A representing the average number of eggs deposited (10 experiments) on the untreated parts, and B on the treated parts.

La moyenne des indices obtenus pour chaque répétition est comparée entre les différents types de traitement. The average of the indices obtained for each repetition is compared between the different types of treatment.

RESULTATS
Les résultats sont présentés dans les Tableaux
III et IV suivants
TABLEAU III - Dissuasion de la ponte obtenue chez la tordeuse de la grappe lors d'une exposition à différents traitements. Id varie de 0 % (pas de dissuasion) à 100 % dissuasion totale. Sd = écart type.RESULTS
The results are presented in the Tables
III and IV following
TABLE III - Deterrence of egg-laying obtained by the budworm when exposed to different treatments. Id varies from 0% (no deterrence) to 100% total deterrence. Sd = standard deviation.

Les lettres entre parenthèses différentes indiquent des différences statistiques avec une probabilité > 99 %.The letters in different parentheses indicate statistical differences with a probability> 99%.

TABLEAU III
Traitement Nb femelles Nb oeufs id+Sd (en %)
Contrôle 133 4967 0,91+ 3,65 (a) (solvant seul)
ODP 60 2176 54,79 + 4,57 (b)
ODP + Thu 44 1065 57,90 + 1,74 (c)
ODP + Thu + Pin 60 1407 60,75 + 3,14 (c)
TABLEAU IV : Nombre moyen d'oeufs déposés par femelle lors de l'exposition aux différents traitements proposés, et réduction du nombre d'oeufs par rapport au contrôle.TABLE III
Treatment Nb females Nb eggs id + Sd (in%)
Control 133 4967 0.91+ 3.65 (a) (solvent only)
ODP 60 2176 54.79 + 4.57 (b)
ODP + Thu 44 1065 57.90 + 1.74 (c)
ODP + Thu + Pin 60 1407 60.75 + 3.14 (c)
TABLE IV: Average number of eggs deposited per female during exposure to the various treatments offered, and reduction in the number of eggs compared to the control.

Sd = écart type
TABLEAU IV
Traitement Nb d'oeuf par
femelle + Sd Réduction (%)
Contrôle 38,91+ 7,98 (solvant seul)
ODP 36,27 + 4,17 6,8 %
ODP + Thu 24,70 + 6,28 36,6 %
ODP + Thu + Pin 23,45 + 10,98 39,7 %. Sd = standard deviation
TABLE IV
Treatment Nb of egg by
female + SD Reduction (%)
Control 38.91+ 7.98 (solvent only)
ODP 36.27 + 4.17 6.8%
ODP + Thu 24.70 + 6.28 36.6%
ODP + Thu + Pin 23.45 + 10.98 39.7%.

CONCLUSION
L'addition de monoterpènes à la formulation synthétique constituée d'acides gras et d'esters d'acides gras
(1) augmente l'effet dissuasif (incite les femelles à pondre sur les zones non traitées).CONCLUSION
The addition of monoterpenes to the synthetic formulation consisting of fatty acids and fatty acid esters
(1) increases the deterrent effect (encourages females to lay eggs on untreated areas).

(2) réduit de plus de 35 % le nombre d'oeufs pondus par jour et par femelle. (2) reduces by more than 35% the number of eggs laid per day and per female.

- Le nombre total d'oeufs déposés par les femelles sur les supports n'est pas affecté par les différents traitements. - The total number of eggs deposited by females on the supports is not affected by the different treatments.

- dans le cas du support témoin (bristol sans traitement), Di = 0,06%, ce qui indique que les dépots d'oeufs sont régulièrement répartis sur toute la superficie du support de ponte ; une répartition similaire est observée dans le cas du support traité au méthanol (Di = 0,65%). - in the case of the control medium (Bristol without treatment), Di = 0.06%, which indicates that the egg deposits are regularly distributed over the entire surface of the laying medium; a similar distribution is observed in the case of the support treated with methanol (Di = 0.65%).

Ainsi que cela ressort de ce qui précède, l'Invention ne se limite nullement à ceux de ses modes de mise en oeuvre, de réalisation et d'application qui viennent d'être décrits de façon plus explicite ; elle en embrasse au contraire toutes les variantes qui peuvent venir à l'esprit du technicien en la matière, sans s'écarter du cadre, ni de la portée de la présente
Invention. As is apparent from the above, the invention is in no way limited to those of its modes of implementation, embodiment and application which have just been described more explicitly; on the contrary, it embraces all variants which may come to the mind of the technician in the matter, without departing from the framework or the scope of this
Invention.

Claims (10)

REVENDICATIONS 1) Composition anti-oviposition, comprenant un composant A, lequel comprend au moins un acide gras non estérifié en Cl2~20 et/ou au moins un ester d'alkyle en C13 et d'acide gras en C1420, laquelle composition est caractérisée en ce qu'elle comprend en outre un composant B comprenant au moins un monoterpène présent dans un extrait obtenu par distillation à la vapeur d'eau de fleurs de tanaisie. 1) Anti-oviposition composition, comprising a component A, which comprises at least one fatty acid not esterified in Cl2 ~ 20 and / or at least one C13 alkyl ester and C1420 fatty acid, which composition is characterized in what it further comprises a component B comprising at least one monoterpene present in an extract obtained by steam distillation of tansy flowers. 2) Composition selon la Revendication 1, caractérisée en ce que ledit monoterpène est choisi dans le groupe comprenant lla-thujone, la ss-thujone et 1 'a-pinène.  2) Composition according to Claim 1, characterized in that said monoterpene is chosen from the group comprising lla-thujone, ss-thujone and 1 a-pinene. 3) Composition selon l'une quelconque des 3) Composition according to any one of Revendications 1 ou 2, caractérisée en ce que le composant A comprend au moins un acide gras choisi dans le groupe qui comprend l'acide myristique, l'acide stéarique et l'acide palmitique, et au moins un méthylester d'acide gras choisi dans le groupe qui comprend le palmitoléate de méthyle, le palmitate de méthyle, le linoléate de méthyle, le linolénate de méthyle, 1'oléate de méthyle, le stéarate de méthyle, et le composant B comprend au moins un monoterpène choisi dans le groupe qui comprend lla-thujone, la 13-thujone et 1 'a-pinène. Claims 1 or 2, characterized in that component A comprises at least one fatty acid chosen from the group which comprises myristic acid, stearic acid and palmitic acid, and at least one fatty acid methylester chosen from the group which comprises methyl palmitoleate, methyl palmitate, methyl linoleate, methyl linolenate, methyl oleate, methyl stearate, and component B comprises at least one monoterpene selected from the group which comprises lla-thujone, 13-thujone and a-pinene. 4) Composition selon la Revendication 3, caractérisée en ce qu'elle comprend, pour une partie de palmitoléate de méthyle, entre 4 et 10 parties de palmitate de méthyle, entre 2 et 5 parties de linoléate de méthyle, entre 2 et 5 parties de linolénate de méthyle, entre 4 et 10 parties d'oléate de méthyle, entre 2 et 5 parties de stéarate de méthyle, entre 2 et 5 parties d'acide myristique, entre 10 et 30 parties d'acide palmitique, entre 2 et 5 parties d'acide stéarique, entre 102 et 106 parties d'a-thujone, entre 10 et 104 parties de ss-thujone et entre 102 et 106 parties d'a-pinène.  4) Composition according to Claim 3, characterized in that it comprises, for a part of methyl palmitoleate, between 4 and 10 parts of methyl palmitate, between 2 and 5 parts of methyl linoleate, between 2 and 5 parts of methyl linolenate, between 4 and 10 parts of methyl oleate, between 2 and 5 parts of methyl stearate, between 2 and 5 parts of myristic acid, between 10 and 30 parts of palmitic acid, between 2 and 5 parts of stearic acid, between 102 and 106 parts of a-thujone, between 10 and 104 parts of ss-thujone and between 102 and 106 parts of a-pinene. 5) Composition selon l'une quelconque des 5) Composition according to any one of Revendications 1 à 4, caractérisée en ce que le composant A comprend au moins 10 ng/ml d'acide myristique, 10 ng/ml d'acide stéarique, 50 ng/ml d'acide palmitique, 5 ng/ml de palmitoléate de méthyle, 20 ng/ml de palmitate de méthyle, 10 ng/ml de linoléate de méthyle, 10 ng/ml de linolénate de méthyle, 20 ng/ml d'oléate de méthyle, 10 ng/ml de stéarate de méthyle, et le composant B comprend 10 mg/ml de ss-thujone, 1 mg/ml d'a-thujone et 10 mg/ml dla-pinène. Claims 1 to 4, characterized in that component A comprises at least 10 ng / ml of myristic acid, 10 ng / ml of stearic acid, 50 ng / ml of palmitic acid, 5 ng / ml of methyl palmitoleate , 20 ng / ml methyl palmitate, 10 ng / ml methyl linoleate, 10 ng / ml methyl linolenate, 20 ng / ml methyl oleate, 10 ng / ml methyl stearate, and the component B includes 10 mg / ml ss-thujone, 1 mg / ml a-thujone and 10 mg / ml dla-pinene. 6) Composition selon la Revendication 5, caractérisée en ce que le composant A comprend entre 20 et 30 ng/ml d'acide myristique, entre 15 et 25 ng/ml d'acide stéarique, entre 100 et 150 ng/ml d'acide palmitique, entre 5 et 10 ng/ml de palmitoléate de méthyle, entre 30 et 80 ng/ml de palmitate de méthyle, entre 20 et 30 ng/ml de linoléate de méthyle, entre 15 et 25 ng/ml de linolénate de méthyle, entre 30 et 80 ng/ml d'oléate de méthyle, entre 25 et 35 ng/ml de stéarate de méthyle, et le composant B comprend entre 15 et 100 mg/ml de B-thujone, entre 2 et 10 mg/ml d'a-thujone, entre 15 et 100 mg/ml d'a-pinène.  6) Composition according to Claim 5, characterized in that the component A comprises between 20 and 30 ng / ml of myristic acid, between 15 and 25 ng / ml of stearic acid, between 100 and 150 ng / ml of acid palmitic, between 5 and 10 ng / ml of methyl palmitoleate, between 30 and 80 ng / ml of methyl palmitate, between 20 and 30 ng / ml of methyl linoleate, between 15 and 25 ng / ml of methyl linolenate, between 30 and 80 ng / ml of methyl oleate, between 25 and 35 ng / ml of methyl stearate, and component B comprises between 15 and 100 mg / ml of B-thujone, between 2 and 10 mg / ml of 'a-thujone, between 15 and 100 mg / ml of a-pinene. 7) Application des composants A et B d'une composition selon l'une quelconque des Revendications 1 à 6, à la protection des plantes contre les Lépidoptères tortricidés. 7) Application of components A and B of a composition according to any one of Claims 1 to 6, for the protection of plants against Tortricid Lepidoptera. 8) Procédé de protection des plantes contre les Lépidoptères tortricidés, lequel procédé est caractérisé en ce que l'on met en contact les plantes à traiter avec le composant A et le composant B d'une composition anti-oviposition, selon l'une quelconque des 8) Process for protecting plants against Lepidopteran tortricidae, which process is characterized in that the plants to be treated are brought into contact with component A and component B of an anti-oviposition composition, according to any one of Revendications 1 à 6.Claims 1 to 6. 9) Procédé selon la Revendication 8, caractérisée en ce qu'on applique simultanément le composant A et le composant B sur les plantes à traiter.  9) Method according to Claim 8, characterized in that component A and component B are applied simultaneously to the plants to be treated. v v 10) Procédé selon la Revendication 8, caractérisée en ce qu'on applique successivement le composant A et le composant B sur les plantes à traiter.  10) Method according to Claim 8, characterized in that component A and component B are successively applied to the plants to be treated.
FR9201506A 1991-07-02 1992-02-11 ANTI-OVIPOSITION COMPOSITIONS COMPRISING A FATTY ACID, A FATTY ACID ALKYLESTER AND A MONOTERPENE. Expired - Fee Related FR2687047B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9201506A FR2687047B1 (en) 1992-02-11 1992-02-11 ANTI-OVIPOSITION COMPOSITIONS COMPRISING A FATTY ACID, A FATTY ACID ALKYLESTER AND A MONOTERPENE.
DE69205428T DE69205428T2 (en) 1991-07-02 1992-07-01 COMPOSITIONS DETERMINING FROM THE EGG PLANT CONTAINING FATTY ACID AND / OR FATTY ACID ESTER AND, IF NECESSARY, A MONOTERPEN.
AT92915124T ATE128809T1 (en) 1991-07-02 1992-07-01 OVO-LAYING DETERRENT COMPOSITIONS CONTAINING A FATTY ACID AND/OR A FATTY ACID ESTER AND, IF APPLICABLE, A MONOTERPENE.
PCT/FR1992/000619 WO1993000812A1 (en) 1991-07-02 1992-07-01 Anti-oviposition compositions including a fatty acid and/or a fatty acid alkyl ester and optionally a monoterpene
CA002111708A CA2111708A1 (en) 1991-07-02 1992-07-01 Anti-oviposition compositions including a fatty acid and/or a fatty acid alkyl ester and optionally a monoterpene
ES92915124T ES2079198T3 (en) 1991-07-02 1992-07-01 COMPOSITIONS THAT PREVENT THE LAYING OF EGGS AND CONTAIN A FATTY ACID AND / OR AN ALKYL ESTER OF FATTY ACID AND EVENTUALLY A MONOTERPEN.
EP92915124A EP0592577B1 (en) 1991-07-02 1992-07-01 Anti-oviposition compositions including a fatty acid and/or a fatty acid alkyl ester and optionally a monoterpene
GR960400040T GR3018620T3 (en) 1991-07-02 1996-01-09 Anti-oviposition compositions including a fatty acid and/or a fatty acid alkyl ester and optionally a monoterpene.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201506A FR2687047B1 (en) 1992-02-11 1992-02-11 ANTI-OVIPOSITION COMPOSITIONS COMPRISING A FATTY ACID, A FATTY ACID ALKYLESTER AND A MONOTERPENE.

Publications (2)

Publication Number Publication Date
FR2687047A1 true FR2687047A1 (en) 1993-08-13
FR2687047B1 FR2687047B1 (en) 1994-05-13

Family

ID=9426519

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9201506A Expired - Fee Related FR2687047B1 (en) 1991-07-02 1992-02-11 ANTI-OVIPOSITION COMPOSITIONS COMPRISING A FATTY ACID, A FATTY ACID ALKYLESTER AND A MONOTERPENE.

Country Status (1)

Country Link
FR (1) FR2687047B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2577385A1 (en) * 1985-02-15 1986-08-22 Basf Ag Process and means for controlling the eudemis moth
DE3734657A1 (en) * 1987-10-13 1989-04-27 Max Planck Gesellschaft Method for controlling the behaviour of harmful insects using volatile signal substances

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2577385A1 (en) * 1985-02-15 1986-08-22 Basf Ag Process and means for controlling the eudemis moth
DE3734657A1 (en) * 1987-10-13 1989-04-27 Max Planck Gesellschaft Method for controlling the behaviour of harmful insects using volatile signal substances

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS vol. 73, no. 8 , 1982, Philadelphia, PA, US; abstract no. 52764, G.J.BREWER ET AL.: 'A feeding deterrent effect of a water extract of tansy (TANACETUM VULGARE, Compositae) on 3 lepidopterous larvae' *
CHEMICAL ABSTRACTS, vol. 85, no. 9, 30 Août 1976, Columbus, Ohio, US; abstract no. 59941r, K.OSHIMA: 'Why do adzuki bean weevils avoid oviposited adzuki beans?' *
ENTOMOLOGIA EXPERIMENTALIS ET APPLICATA vol. 41, 1986, DORDRECHT, NL pages 139 - 146 J.W.KLIJNSTRA: 'The effect of an oviposi tion deterring pheromone on egglaying in PIERIS BRASSICAE' *
JOURNAL OF APPLIED ENTOMOLOGY vol. 113, no. 2, 1992, HAMBURG, DE; pages 153 - 158 B.GABEL: 'Tansy flowers attract European grapevine moth females LOBESIA BOTRANA Den. & Schiff. (Lep., Tortricidae)' *
JOURNAL OF CHEMICAL ECOLOGY vol. 10, no. 1, 1984, NEW YORK, US; pages 145 - 151 Y.-S. HWANG ET AL.: 'Structure-Activity Relationship of Unsaturated fatty acids as Mosquito ovipostional Repellents' *
JOURNAL OF CHEMICAL ECOLOGY vol. 7, no. 1, 1981, NEW YORK, US; pages 39 - 48 R.I.ALFARO ET AL.: 'Insect Feeding and Oviposition Deterrents from Western Cedar Foliage' *
NATURWISSENSCHAFTEN vol. 78, no. 3, Mars 1991, BERLIN, DE; pages 132 - 133 D.THIÉRY ET AL.: 'Identification of an Oviposition-Deterring Pheromone in the Eggs of the European Corn Borer' *

Also Published As

Publication number Publication date
FR2687047B1 (en) 1994-05-13

Similar Documents

Publication Publication Date Title
FR2464648A1 (en) LIQUID INSECTICIDAL COMPOSITIONS CONTAINING SYNTHETIC PYRETHROIDS
Gabel et al. Oviposition response of Lobesia botrana females to long-chain free fatty acids and esters from its eggs
EP0961546A1 (en) Additive composition for plant protection
US20040242699A1 (en) Compounds to affect insect behavior and to enhance insecticides
Moritya et al. Attraction of the male brown-winged green bug, Plautia stali Scott (Heteroptera: Pentatomidae) for males and females of the same species
DE3543297A1 (en) Composition for controlling bark beetles
EP0629345B1 (en) Insecticidal/acaricidal composition based on anionic surfactant(s), and semiochemical(s), and method for combatting arthropods using this composition
EP0592577B1 (en) Anti-oviposition compositions including a fatty acid and/or a fatty acid alkyl ester and optionally a monoterpene
Jackson et al. 3-Ethyl-2, 5-dimethylpyrazine, a component of the trail pheromone of the ant Messor bouvieri
FR2687047A1 (en) Anti-oviposition compositions comprising a fatty acid, a fatty acid alkyl ester and a monoterpene
US5650160A (en) Inclusion complexes of cyclodextrin and their use in slow release formulations for attracting insects
Gabel et al. Biological evidence of an oviposition-deterring pheromone in Lobesia botrana Den. et Schiff.(Lepidoptera, Tortricidae)
Sullivan et al. Influence of the plant antifeedant, pinosylvin, on suppression of feeding by snowshoe hares
EP0495955A1 (en) Oviposition-preventing pheromone containing at least one fatty acid alkyl ester, and uses thereof for controlling crop-destroying insects
US20030124165A1 (en) Insect repellent composition comprising tarchonanthus comphoratus and repellency enhancer
EP0762832B1 (en) Use of at least one fatty acid for the control of tortricid lepidoptera oviposition
FR3063872A1 (en) VEGETABLE PYRETHRE COMPOSITION FOR THE CONTROL OF HARMFUL ARTHROPODS
Kawada et al. Effects of pyriproxyfen on the reproduction of the housefly, Musca domestica, and the German cockroach, Blattella germanica
EP0784428B1 (en) Method for controlling the allergenicity of house dust mites and their dejecta
Seawright et al. Tepa and thiotepa: uptake, persistence, and sterility induced in pupae and adults of Culex pipiens quinquefasciatus
WO1997014298A1 (en) Composition for treating poultry litter
JP2002504141A (en) Compositions containing flat breast oil or active fraction thereof and methods of using those compositions as insect repellents
BE484137A (en)
FR2678483A1 (en) Anti-oviposition pheromone comprising at least one fatty acid and/or one fatty acid alkyl ester, and its application to the control of tortricid Lepidoptera
Thiéry et al. Anti oviposition compositions including fatty acids and/or fatty acids alkyl esters and optionally monoterpenes

Legal Events

Date Code Title Description
R1 Appeal
DS Decision of the director general to state about an appeal
ST Notification of lapse